Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.0800
-0.0030 (-3.61%)
Apr 15, 2026, 9:27 AM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 101.89 million as of April 15, 2026. Its market cap has decreased by -40.71% in one year.
Market Cap
101.89M
Enterprise Value
109.44M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.08
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 101.89M, a decrease of -86.72%. That is a compound annual growth rate of -48.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 101.89M | -11.13% |
| Dec 30, 2025 | 114.65M | -50.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.07T |
| Genmab | 109.89B |
| Coloplast | 96.48B |
| ALK-Abelló | 47.15B |
| ChemoMetec | 5.28B |
| BioPorto | 480.26M |
| ViroGates | 103.03M |
| Scandinavian Medical Solutions | 83.42M |